Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joy Tang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|December 4, 2012
The role of microRNAs in breast cancer migration, invasion and metastasisJoy Tang, Aamir Ahmad, Fazlul H Sarkar
Current Pharmaceutical Design|February 1, 2014
MicroRNAs in breast cancer therapyJoy Tang, Aamir Ahmad, Fazlul H Sarkar
Best Practice & Research. Clinical Haematology|April 1, 2019
Stem cell damage after chemotherapy- can we do better?Joy Tang, Nan Zhu, Sridhar Rao, et al.
Frontiers in Pharmacology|February 15, 2013
Erlotinib resistance in lung cancer: current progress and future perspectivesJoy Tang, Rasha Salama, Shirish M Gadgeel, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|January 15, 2016
Assessing Fluid Responsiveness in Spontaneously Breathing PatientsJoseph Miller, Chuan-Xing Ho, Joy Tang, et al.
Expert Review of Anticancer Therapy|July 5, 2022
Risk factors and predictors of immune-related adverse events: implications for patients with non-small cell lung cancerMajd Issa, Joy Tang, Yizhen Guo, et al.
Frontiers in Medicine|December 1, 2022
Lack of direct association between viral hepatitis and sleep disturbancesSheng-Jie Lin, Shang-Ching Joy Tang, Yu-Chia Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|September 14, 2024
Functional resilience and overall survival in adults treated for advanced non-small-cell lung cancerCarolyn J Presley, Joy Tang, Jason Benedict, et al.
NPJ Precision Oncology|April 26, 2022
Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomasNathan D Seligson, Joy Tang, Dexter X Jin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|December 4, 2012
The role of microRNAs in breast cancer migration, invasion and metastasisJoy Tang, Aamir Ahmad, Fazlul H Sarkar
Current Pharmaceutical Design|February 1, 2014
MicroRNAs in breast cancer therapyJoy Tang, Aamir Ahmad, Fazlul H Sarkar
Best Practice & Research. Clinical Haematology|April 1, 2019
Stem cell damage after chemotherapy- can we do better?Joy Tang, Nan Zhu, Sridhar Rao, et al.
Frontiers in Pharmacology|February 15, 2013
Erlotinib resistance in lung cancer: current progress and future perspectivesJoy Tang, Rasha Salama, Shirish M Gadgeel, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|January 15, 2016
Assessing Fluid Responsiveness in Spontaneously Breathing PatientsJoseph Miller, Chuan-Xing Ho, Joy Tang, et al.
Expert Review of Anticancer Therapy|July 5, 2022
Risk factors and predictors of immune-related adverse events: implications for patients with non-small cell lung cancerMajd Issa, Joy Tang, Yizhen Guo, et al.
Frontiers in Medicine|December 1, 2022
Lack of direct association between viral hepatitis and sleep disturbancesSheng-Jie Lin, Shang-Ching Joy Tang, Yu-Chia Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|September 14, 2024
Functional resilience and overall survival in adults treated for advanced non-small-cell lung cancerCarolyn J Presley, Joy Tang, Jason Benedict, et al.
NPJ Precision Oncology|April 26, 2022
Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomasNathan D Seligson, Joy Tang, Dexter X Jin, et al.
Pageof 1